PCOM2 - The Physician Communication Intervention, Version 2.0 for Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake

What this Trial Is About

Researchers are evaluating two versions of a provider communication intervention called PCOM to increase human papillomavirus (HPV) vaccination rates among adolescents aged 9 to 17 years. The study aims to develop and test a virtual version of the intervention (PCOM-Virtual) against the original in-person PCOM intervention (PCOM-Standard). This comparison will help determine whether the virtual method can be as effective and easier to spread widely, addressing low vaccination rates that leave many adolescents at risk for HPV-related cancers and diseases. The study involves two groups of primary care providers: one trained in the traditional in-person PCOM communication technique and the other trained through the newly developed virtual PCOM version. Both interventions teach providers to use a two-step communication approach: starting vaccine discussions with a presumptive style, followed by motivational interviewing to address parental hesitancy. The virtual version also aims to produce a ready-to-use intervention and user manual for easy adoption in clinical practices. Participants include adolescents receiving care at enrolled clinics and their providers. Researchers will track HPV vaccination initiation and completion in adolescents aged 11 to 12 and 13 to 17 years during the last 12 months of the 24-month intervention period. Data collection will include monitoring vaccination status and analyzing how practice, patient, and provider characteristics influence the interventions' effectiveness. The study runs until the end of 2026 and involves random assignment of providers to the two intervention groups with single masking.

PCOM2 - The Physician Communication Intervention, Version 2.0